Haier Biological Disclosure achieved revenue of 1.268 billion yuan in the semi -annual report of 2022

On August 25, A -share listed company Haier Biological (code: 688139.SH) released the semi -annual performance report in 2022.

From January 1, 2022-June 30, 2022, the company realized operating income of 1.268 billion yuan, an increase of 36.63%year-on-year, and a net profit of 301 million yuan, a year-on-year decrease of 47.55%, and the basically earnings per share were 0.95 yuan.

The company's industry is a medical device.

During the company's reporting period, the total assets at the end of the period were 5.088 billion yuan, the operating profit was 333 million yuan, the accounts receivable were 122 million yuan, and the net cash flow generated by operating activities was 184 million yuan.Cash was 1.338 billion yuan.

Haier Biological, the company's full known as Qingdao Haier Biomedical Co., Ltd., was established on October 28, 2005. The current general manager Liu Zhanjie, the main business is the research and development, production and sales of biomedical low -temperature storage equipment.

- END -